**Sanofi Consumer Healthcare India Q4 Results 2025**
On February 20, 2025, Sanofi Consumer Healthcare India announced its Q4 results, revealing a year-over-year (YoY) decline in topline revenue of 20.53% and a profit decrease of 34.66%. The company’s profit for the quarter was ₹44.3 crore, with revenue totaling ₹170.7 crore.
When comparing Q4 to the previous quarter, revenue experienced a modest increase of 6.75%, while profit saw a slight decline of 1.56%. This revenue growth suggests some resilience despite the overall annual downturn.
Selling, General & Administrative expenses rose by 0.73% quarter-over-quarter (q-o-q) and surged by 42.27% YoY, indicating increased operational costs that have adversely affected profitability. Operating income also faced challenges, decreasing by 3.64% q-o-q and 33.03% YoY, highlighting ongoing pressure on the company’s earnings capacity.
Earnings per share (EPS) for Q4 was reported at ₹20.14, reflecting a significant drop of 32.93% YoY, which underscores the decline in profitability.
On a positive note, as of February 21, 2025, one analyst covering the company has issued a consensus recommendation of Strong Buy, suggesting potential confidence in future recovery. The overall consensus remains Strong Buy, indicating optimism among analysts despite the current financial challenges faced by Sanofi Consumer Healthcare India.
**Sanofi Consumer Healthcare India Financials**
| Period | Q4 (FY24) | Q3 (FY24) | Q-o-Q Growth | Q4 (FY23) | Y-o-Y Growth |
|—————————|———–|———–|————–|———–|————–|
| Total Revenue | 170.7 | 159.9 | +6.75% | 214.8 | -20.53% |
| Selling/General/Admin Expenses Total | 27.6 | 27.4 | +0.73% | 19.4 | +42.27% |
| Depreciation/Amortization | 11.5 | – | – | 0.9 | +11.11% |
| Total Operating Expense | 112.5 | 99.5 | +13.07% | 127.9 | -12.04% |
| Operating Income | 58.2 | 60.4 | -3.64% | 86.9 | -33.03% |
| Net Income Before Taxes | 62.8 | 61.2 | +2.61% | 89.5 | -29.83% |
| Net Income | 44.3 | 45.0 | -1.56% | 67.8 | -34.66% |
| Diluted Normalized EPS | 20.14 | 19.92 | +1.1% | 30.03 | -32.93% |
Stay updated on quarterly results with our results calendar.
